About Epygenix Therapeutics, Inc.
Epygenix Therapeutics, Inc. is developing precision medicine for rare and catastrophic forms of genetic epilepsy, such as Dravet Syndrome, Lennox-Gastaut Syndrome, Infantile Spasm, and Otahara syndrome.
State of Ownership
Business Development Associate Director, University of Michigan
Business Development Executive, Nature Publishing Group, Springer Nature